FeesSafety
Pluang+

Bitcoin ETFs see $399M outflows as November starts with weak institutional demand.

Market News
03 Nov 2026, 16:30 WIB
Bitcoin
View Source
Bearish
Bitcoin ETFs see $399M outflows as November starts with weak institutional demand.

Bitcoin ETFs experienced $398.62 million in outflows on Monday, continuing a trend from Friday that pushed two-day withdrawals above $1.04 billion. Blackrock's IBIT fund led the sell-off with $405.30 million exiting, signaling a shift in institutional appetite that could pressure Bitcoin's price. Ether ETFs also faced $139.80 million in redemptions, marking a sixth straight day of outflows and highlighting ongoing weak demand. Smaller altcoin ETFs showed minimal activity, reflecting cautious investor sentiment as November begins with subdued risk appetite across crypto products.

Bitcoin ETFs saw outflows totaling $398.62 million on Monday, part of a two-day withdrawal exceeding $1.04 billion. For readers following the cryptocurrency market, here is Pluang's market snapshot as of Nov 03, 2026 21:24 WIB: out of 50 major cryptocurrencies, 20 rose and 29 fell today. Notable movers include VET (VeChain) at Rp102 with a 1-day change of -1.84% and a Pluang order activity of 46% Sell / 54% Buy, AXS (Axie Infinity) at Rp15,241 with a 1-day change of -1.84% and 38% Sell / 62% Buy, and THETA (Theta Network) at Rp2,730 with a 1-day change of -1.76% and 0% Sell / 100% Buy.

More News

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
2 hours ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
2 hours ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
2 hours ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
3 hours ago
Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App